Uruguay | Imports and Exports | World | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Uruguay totalled $ 77 million in 2023. Sales of commodity group 3002 from Uruguay went up by 2.17% compared to 2022: exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" went up by $ 1.65 million (cumulative exports of commodity group 3002 from Uruguay amounted $76 million in 2022)
Exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" amounted to 0.847% of total exports from Uruguay (cumulative merchandise exports from Uruguay totalled $ 9.19 billion in 2023). The share of commodity group 3002 in total exports from Uruguay increased by 0.166 p.p. compared to 2022 (it was 0.681% in 2022 and cumulative exports from Uruguay were equal to $ 11.1 billion).
Exports of commodity group 3002 amounted to 44% of total sales of group "" from Uruguay in 2023 (the value of exports of commodity group from Uruguay amounted to $174 million in 2023). The share of exports of commodity group 3002 in sales of commodity group from Uruguay increased by 3.42 p.p. compared to 2022 (it was 41% in 2022, and exports of commodity group from Uruguay were $184 million).
Where does Uruguay export Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc?
Top export destinations of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Uruguay in 2023:
- China with a share of 24% (18.8 million US$)
- Paraguay with a share of 14.2% (11.1 million US$)
- Brazil with a share of 13.8% (10.8 million US$)
- Colombia with a share of 7.77% (6.06 million US$)
- Ecuador with a share of 6.32% (4.92 million US$)
- South Africa with a share of 5.83% (4.55 million US$)
- Peru with a share of 5.09% (3.97 million US$)
- Guatemala with a share of 4.95% (3.86 million US$)
- Argentina with a share of 3.69% (2.87 million US$)
- Bolivia with a share of 2.64% (2.05 million US$)
Exports structure of 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc - from Uruguay in 2023 represented by the following main commodity groups:
- 5.08% (3.96 million US$): 300290 - Human blood; animal blood prepared for therapeutic/prophylactic/diagnostic uses; toxins, cultures of micro-organisms (excl. yeasts) & sim. products
The value of imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to Uruguay totalled $ 135 million in 2023. Sales of commodity group 3002 to Uruguay went up by 3.84% compared to 2022: imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" went up by $ 5.02 million (the value of imports of commodity group 3002 to Uruguay was equal to $130 million in 2022)
Imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" accounted for 1.08% of total import flow to Uruguay (in 2023, total imports to Uruguay amounted to $ 12.4 billion). The share of commodity group 3002 in total imports to Uruguay increased by 0.079 p.p. compared to 2022 (it was 1% in 2022 and cumulative imports to Uruguay were equal to $ 12.9 billion).
Imports of commodity group 3002 reached 35% of total imports of group "" to Uruguay in 2023 (imports of commodity group to Uruguay totalled $380 million in 2023). The share of purchases of commodity group 3002 in imports of commodity group to Uruguay went down by 0.583 p.p. compared to 2022 (it was 36% in 2022, and imports of commodity group to Uruguay accounted for $360 million).
Where does Uruguay import Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc from?
Top trading partners (import of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc") of Uruguay in 2023:
- Germany with a share of 19.7% (26 million US$)
- Ireland with a share of 13% (17.7 million US$)
- Brazil with a share of 10.3% (14 million US$)
- Switzerland with a share of 9.49% (12.8 million US$)
- USA with a share of 8.7% (11.8 million US$)
- Argentina with a share of 7.68% (10.4 million US$)
- Japan with a share of 4.01% (5.45 million US$)
- Korea with a share of 3.32% (4.5 million US$)
- Italy with a share of 2.83% (3.84 million US$)
- Netherlands with a share of 2.82% (3.83 million US$)
Imports structure of 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc - to Uruguay in 2023 represented by the following main commodity groups:
- 2.64% (3.58 million US$): 300290 - Human blood; animal blood prepared for therapeutic/prophylactic/diagnostic uses; toxins, cultures of micro-organisms (excl. yeasts) & sim. products
